NIH-funded research R01 grant

Role of miR98 in heart injury during late pregnancy

Official title: Role of miR98 in Myocardial Ischemia Reperfusion Injury in Pregnancy

Funded at University of California Los Angeles · NIH-11367676 · Data updated 2026-11-12

A study in pregnant people or models will look at how a tiny molecule called miR98 affects heart injury after a heart attack during the third trimester.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJune 15, 2026
Project endMarch 31, 2030
Funding year2026
Award (this year)$531,794
NIH project number1R01HL181340-01A1
Project IDNIH-11367676 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants would be adults in the third trimester of pregnancy or, where applicable, patient samples and models that reflect late-pregnancy heart biology.

Less likely to help

Non-pregnant individuals or those without heart injury may not directly benefit from these findings.

What this research studies

This research explores why the heart is more vulnerable to injury during late pregnancy and whether miR98 helps or worsens that injury. It uses data from human adults in the context of pregnancy and may include pregnancy-specific heart biology, along with animal or cellular models to study mechanisms. The team will examine how miR98 behaves in heart cells and immune cells during ischemia-reperfusion injury and how hormones like estradiol influence it. Results could point toward new ideas for protecting the pregnant heart from damage during a heart attack.

Why it matters

Potential benefit: If successful, findings could lead to strategies to reduce heart damage in late-pregnancy patients who have a heart attack.

How similar studies have gone: Prior data in animals and humans suggest a link between miR98 and heart injury, but pregnancy-specific effects are still being explored.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Eghbali, Mansoureh — University of California Los Angeles
  • Study coordinator: Eghbali, Mansoureh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.